MetaCap

Astrana Health (ASTH) vs Everforth (EFOR)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Astrana Health (ASTH) has outperformed Everforth (EFOR) over the past year, gaining 28.4% versus a loss of 27.1%. Over five years, ASTH leads with a -69.4% price change compared with -74.3% for EFOR. Astrana Health is the larger company by market cap ($1.44 billion vs $1.29 billion), about 1.1 times the size.

On valuation, Everforth trades at a lower forward P/E (7.4x vs 8.3x for Astrana Health). Everforth converts more of its revenue into profit, with a net margin of 2.9% versus 0.7%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ASTH+28.44%EFOR-27.15%
+130%+31%-69%
Nov 21, 20251 yearNov 20, 2026
ASTH-74.53%EFOR-75.06%
+5%-43%-90%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ASTH versus EFOR key metrics
MetricASTHEFOR
Share price$28.90$31.32
Market cap$1.44B$1.29B
1-day change+0.77%+7.89%
YTD return+16.49%-34.98%
1-year return+28.44%-27.15%
5-year return-69.44%-74.28%
P/E ratio (TTM)26.7619.21
Forward P/E8.307.39
EPS (TTM)$1.08$1.63
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$3.18B$3.98B
Revenue growth (YoY)+56.39%-2.91%
Net income (latest FY)$22.49M$113.50M
Gross margin10.73%28.87%
Operating margin2.47%5.79%
Net margin0.71%2.85%
52-week high$51.60$54.94
52-week low$18.08$16.90
Distance from 52-week high-43.99%-42.99%
Analyst consensusstrong_buynone
Avg. price target upside+79.55%+22.92%
Average volume377.18K697.51K
Shares outstanding49.67M41.10M
Employees3,0002,800
SectorConsumer DiscretionaryConsumer Discretionary
IndustryProfessional ServicesProfessional Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • ASTH has outperformed EFOR by 55.6 percentage points over the past year.
  • Astrana Health trades at a higher earnings multiple (26.8x vs 19.2x trailing P/E).
  • Astrana Health grew revenue faster in its latest fiscal year (+56.39% vs -2.91%).

About Astrana Health

ASTH stock →

Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement.

Consumer Discretionary · Professional Services · 3,000 employees

About Everforth

EFOR stock →

Everforth, Inc. provides information technology solutions for commercial and government sectors in the United States, Canada, and Europe.

Consumer Discretionary · Professional Services · 2,800 employees

ASTH vs EFOR FAQ

Which is bigger, Astrana Health or Everforth?

Astrana Health (ASTH) is larger, with a market capitalization of $1.44B compared with $1.29B for Everforth (EFOR).

Which stock has performed better over the past year, ASTH or EFOR?

ASTH returned +28.44% over the past 12 months, compared with -27.15% for EFOR (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, ASTH or EFOR?

EFOR has the lower trailing P/E at 19.2, versus 26.8 for ASTH. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Are Astrana Health and Everforth in the same industry?

Yes. Both are classified in the Professional Services industry within the Consumer Discretionary sector.

More comparisons